These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 35789177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway.
    Lima IVA, Bellozi PMQ, Batista EM, Vilela LR, Brandão IL, Ribeiro FM, Moraes MFD, Moreira FA, de Oliveira ACP.
    Neuropharmacology; 2020 Oct 01; 176():108156. PubMed ID: 32574650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation.
    Wang L, Wu X, Yang G, Hu N, Zhao Z, Zhao L, Li S.
    Neuroscience; 2022 Aug 21; 498():64-72. PubMed ID: 35792194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2.
    Yu Y, Yang Z, Jin B, Qin X, Zhu X, Sun J, Huo L, Wang R, Shi Y, Jia Z, Shi YS, Chu S, Kong D, Zhang W.
    Pharmacol Res; 2020 Nov 21; 161():105128. PubMed ID: 32805354
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
    Kaplan JS, Stella N, Catterall WA, Westenbroek RE.
    Proc Natl Acad Sci U S A; 2017 Oct 17; 114(42):11229-11234. PubMed ID: 28973916
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interactions between cannabidiol and Δ9 -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome.
    Anderson LL, Low IK, McGregor IS, Arnold JC.
    Br J Pharmacol; 2020 Sep 17; 177(18):4261-4274. PubMed ID: 32608111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
    Yousaf M, Chang D, Liu Y, Liu T, Zhou X.
    Molecules; 2022 Aug 04; 27(15):. PubMed ID: 35956911
    [Abstract] [Full Text] [Related]

  • 16. The effects of cannabidiol and Δ9-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model.
    Dlugosz L, Zhou HZ, Scott BW, Burnham M.
    Epilepsy Res; 2023 Feb 04; 190():107087. PubMed ID: 36646020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy.
    Lazarini-Lopes W, Do Val-da Silva RA, da Silva-Júnior RMP, Silva-Cardoso GK, Leite-Panissi CRA, Leite JP, Garcia-Cairasco N.
    Epilepsy Behav; 2021 Jun 04; 119():107962. PubMed ID: 33887676
    [Abstract] [Full Text] [Related]

  • 20. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
    Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ.
    J Pharmacol Exp Ther; 2010 Feb 04; 332(2):569-77. PubMed ID: 19906779
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.